Loading…

Expression and prognostic significance of prothymosin-α and ERp57 in human gastric cancer

Purpose Prothymosin-α and ERp57 were previously identified as markers for gastric metaplasia in a mouse model of Helicobacter-induced gastric metaplasia and neoplasia. In this paper we assess whether the expression of these putative biomarkers in humans is correlated with gastric metaplasia and aden...

Full description

Saved in:
Bibliographic Details
Published in:Surgery 2007, Vol.141 (1), p.41-50
Main Authors: Leys, Charles M., MD, MSCI, Nomura, Sachiyo, MD, PhD, LaFleur, Bonnie J., PhD, Ferrone, Soldano, MD, PhD, Kaminishi, Michio, MD, PhD, Montgomery, Elizabeth, MD, Goldenring, James R., MD, PhD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c409t-d86dd7ff6d2737fd8699d7322b7aa5f68f2e7a4b8d518c3975573ce79e55b2623
cites cdi_FETCH-LOGICAL-c409t-d86dd7ff6d2737fd8699d7322b7aa5f68f2e7a4b8d518c3975573ce79e55b2623
container_end_page 50
container_issue 1
container_start_page 41
container_title Surgery
container_volume 141
creator Leys, Charles M., MD, MSCI
Nomura, Sachiyo, MD, PhD
LaFleur, Bonnie J., PhD
Ferrone, Soldano, MD, PhD
Kaminishi, Michio, MD, PhD
Montgomery, Elizabeth, MD
Goldenring, James R., MD, PhD
description Purpose Prothymosin-α and ERp57 were previously identified as markers for gastric metaplasia in a mouse model of Helicobacter-induced gastric metaplasia and neoplasia. In this paper we assess whether the expression of these putative biomarkers in humans is correlated with gastric metaplasia and adenocarcinoma and clinical outcomes. Methods Eight tissue microarrays, containing 749 paraffin-embedded tissue cores from 164 gastric cancer patients, were stained for prothymosin-α and ERp57 by horseradish peroxidase immunohistochemical techniques. The proportion of stained cells per core was quantitated using the Ariol SL-50 automated image analysis system. Results Prothymosin-α stained a significantly higher percentage of nuclei in cancer and metastases compared with normal gastric mucosa. ERp57 staining was significantly decreased in cancer and metastases compared with both normal gastric mucosa and metaplasias. ERp57 expression also correlated with greater depth of tumor invasion and advanced stage of disease. Kaplan-Meier survival analysis determined that tumors with the highest quartile of ERp57 expression were statistically associated with longer postoperative survival. A Cox proportional hazard analysis showed that maintenance of ERp57 expression was associated with longer postoperative survival. Conclusions These results suggest that although prothymosin-α is overexpressed in gastric adenocarcinoma, it is not associated with alterations in survival. In contrast, loss of ERp57 expression correlated with more aggressive disease and could provide useful prognostic information for gastric cancer patients.
doi_str_mv 10.1016/j.surg.2006.05.009
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68377624</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0039606006003461</els_id><sourcerecordid>68377624</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-d86dd7ff6d2737fd8699d7322b7aa5f68f2e7a4b8d518c3975573ce79e55b2623</originalsourceid><addsrcrecordid>eNp9kd1qFDEYhoModlu9AQ9kjjybMT-TZAZEkLJaoVBo9cSTkM3PNutMsuabEfeyvBGvyUx3QeiBEAghz_uSPB9CrwhuCCbi7a6BOW8birFoMG8w7p-gFeGM1pIJ8hStMGZ9LbDAZ-gcYIcL0ZLuOTojknQdEWKFvq1_7bMDCClWOtpqn9M2JpiCqSBsY_DB6GhclfxyNd0fxgQh1n9-P9Dr2z2XVYjV_TzqWG01TLkkHyL5BXrm9QDu5Wm_QF8_rr9cXtXXN58-X364rk2L-6m2nbBWei8slUz6cux7KxmlG6k196Lz1EndbjrLSWdYLzmXzDjZO843VFB2gd4ce8sDf8wOJjUGMG4YdHRpBiU6JqWgbQHpETQ5AWTn1T6HUeeDIlgtRtVOLUbVYlRhroqvEnp9ap83o7P_IieFBXh3BFz548_gsgITXBFgQ3ZmUjaF__e_fxQ3Q4jF-vDdHRzs0pxjsaeIAqqwultmuox0WawVhP0FY9mdew</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68377624</pqid></control><display><type>article</type><title>Expression and prognostic significance of prothymosin-α and ERp57 in human gastric cancer</title><source>Elsevier</source><creator>Leys, Charles M., MD, MSCI ; Nomura, Sachiyo, MD, PhD ; LaFleur, Bonnie J., PhD ; Ferrone, Soldano, MD, PhD ; Kaminishi, Michio, MD, PhD ; Montgomery, Elizabeth, MD ; Goldenring, James R., MD, PhD</creator><creatorcontrib>Leys, Charles M., MD, MSCI ; Nomura, Sachiyo, MD, PhD ; LaFleur, Bonnie J., PhD ; Ferrone, Soldano, MD, PhD ; Kaminishi, Michio, MD, PhD ; Montgomery, Elizabeth, MD ; Goldenring, James R., MD, PhD</creatorcontrib><description>Purpose Prothymosin-α and ERp57 were previously identified as markers for gastric metaplasia in a mouse model of Helicobacter-induced gastric metaplasia and neoplasia. In this paper we assess whether the expression of these putative biomarkers in humans is correlated with gastric metaplasia and adenocarcinoma and clinical outcomes. Methods Eight tissue microarrays, containing 749 paraffin-embedded tissue cores from 164 gastric cancer patients, were stained for prothymosin-α and ERp57 by horseradish peroxidase immunohistochemical techniques. The proportion of stained cells per core was quantitated using the Ariol SL-50 automated image analysis system. Results Prothymosin-α stained a significantly higher percentage of nuclei in cancer and metastases compared with normal gastric mucosa. ERp57 staining was significantly decreased in cancer and metastases compared with both normal gastric mucosa and metaplasias. ERp57 expression also correlated with greater depth of tumor invasion and advanced stage of disease. Kaplan-Meier survival analysis determined that tumors with the highest quartile of ERp57 expression were statistically associated with longer postoperative survival. A Cox proportional hazard analysis showed that maintenance of ERp57 expression was associated with longer postoperative survival. Conclusions These results suggest that although prothymosin-α is overexpressed in gastric adenocarcinoma, it is not associated with alterations in survival. In contrast, loss of ERp57 expression correlated with more aggressive disease and could provide useful prognostic information for gastric cancer patients.</description><identifier>ISSN: 0039-6060</identifier><identifier>EISSN: 1532-7361</identifier><identifier>DOI: 10.1016/j.surg.2006.05.009</identifier><identifier>PMID: 17188166</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Adenocarcinoma - metabolism ; Adenocarcinoma - mortality ; Adenocarcinoma - pathology ; Biomarkers, Tumor - metabolism ; Down-Regulation ; Endoplasmic Reticulum - metabolism ; Humans ; Immunohistochemistry ; Metaplasia - metabolism ; Molecular Chaperones - metabolism ; Prognosis ; Protein Array Analysis ; Protein Disulfide-Isomerases - metabolism ; Protein Precursors - metabolism ; Retrospective Studies ; Stomach - metabolism ; Stomach - pathology ; Stomach Neoplasms - metabolism ; Stomach Neoplasms - mortality ; Stomach Neoplasms - pathology ; Surgery ; Survival Rate ; Thymosin - analogs &amp; derivatives ; Thymosin - metabolism</subject><ispartof>Surgery, 2007, Vol.141 (1), p.41-50</ispartof><rights>Mosby, Inc.</rights><rights>2007 Mosby, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-d86dd7ff6d2737fd8699d7322b7aa5f68f2e7a4b8d518c3975573ce79e55b2623</citedby><cites>FETCH-LOGICAL-c409t-d86dd7ff6d2737fd8699d7322b7aa5f68f2e7a4b8d518c3975573ce79e55b2623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4021,27921,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17188166$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leys, Charles M., MD, MSCI</creatorcontrib><creatorcontrib>Nomura, Sachiyo, MD, PhD</creatorcontrib><creatorcontrib>LaFleur, Bonnie J., PhD</creatorcontrib><creatorcontrib>Ferrone, Soldano, MD, PhD</creatorcontrib><creatorcontrib>Kaminishi, Michio, MD, PhD</creatorcontrib><creatorcontrib>Montgomery, Elizabeth, MD</creatorcontrib><creatorcontrib>Goldenring, James R., MD, PhD</creatorcontrib><title>Expression and prognostic significance of prothymosin-α and ERp57 in human gastric cancer</title><title>Surgery</title><addtitle>Surgery</addtitle><description>Purpose Prothymosin-α and ERp57 were previously identified as markers for gastric metaplasia in a mouse model of Helicobacter-induced gastric metaplasia and neoplasia. In this paper we assess whether the expression of these putative biomarkers in humans is correlated with gastric metaplasia and adenocarcinoma and clinical outcomes. Methods Eight tissue microarrays, containing 749 paraffin-embedded tissue cores from 164 gastric cancer patients, were stained for prothymosin-α and ERp57 by horseradish peroxidase immunohistochemical techniques. The proportion of stained cells per core was quantitated using the Ariol SL-50 automated image analysis system. Results Prothymosin-α stained a significantly higher percentage of nuclei in cancer and metastases compared with normal gastric mucosa. ERp57 staining was significantly decreased in cancer and metastases compared with both normal gastric mucosa and metaplasias. ERp57 expression also correlated with greater depth of tumor invasion and advanced stage of disease. Kaplan-Meier survival analysis determined that tumors with the highest quartile of ERp57 expression were statistically associated with longer postoperative survival. A Cox proportional hazard analysis showed that maintenance of ERp57 expression was associated with longer postoperative survival. Conclusions These results suggest that although prothymosin-α is overexpressed in gastric adenocarcinoma, it is not associated with alterations in survival. In contrast, loss of ERp57 expression correlated with more aggressive disease and could provide useful prognostic information for gastric cancer patients.</description><subject>Adenocarcinoma - metabolism</subject><subject>Adenocarcinoma - mortality</subject><subject>Adenocarcinoma - pathology</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Down-Regulation</subject><subject>Endoplasmic Reticulum - metabolism</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Metaplasia - metabolism</subject><subject>Molecular Chaperones - metabolism</subject><subject>Prognosis</subject><subject>Protein Array Analysis</subject><subject>Protein Disulfide-Isomerases - metabolism</subject><subject>Protein Precursors - metabolism</subject><subject>Retrospective Studies</subject><subject>Stomach - metabolism</subject><subject>Stomach - pathology</subject><subject>Stomach Neoplasms - metabolism</subject><subject>Stomach Neoplasms - mortality</subject><subject>Stomach Neoplasms - pathology</subject><subject>Surgery</subject><subject>Survival Rate</subject><subject>Thymosin - analogs &amp; derivatives</subject><subject>Thymosin - metabolism</subject><issn>0039-6060</issn><issn>1532-7361</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNp9kd1qFDEYhoModlu9AQ9kjjybMT-TZAZEkLJaoVBo9cSTkM3PNutMsuabEfeyvBGvyUx3QeiBEAghz_uSPB9CrwhuCCbi7a6BOW8birFoMG8w7p-gFeGM1pIJ8hStMGZ9LbDAZ-gcYIcL0ZLuOTojknQdEWKFvq1_7bMDCClWOtpqn9M2JpiCqSBsY_DB6GhclfxyNd0fxgQh1n9-P9Dr2z2XVYjV_TzqWG01TLkkHyL5BXrm9QDu5Wm_QF8_rr9cXtXXN58-X364rk2L-6m2nbBWei8slUz6cux7KxmlG6k196Lz1EndbjrLSWdYLzmXzDjZO843VFB2gd4ce8sDf8wOJjUGMG4YdHRpBiU6JqWgbQHpETQ5AWTn1T6HUeeDIlgtRtVOLUbVYlRhroqvEnp9ap83o7P_IieFBXh3BFz548_gsgITXBFgQ3ZmUjaF__e_fxQ3Q4jF-vDdHRzs0pxjsaeIAqqwultmuox0WawVhP0FY9mdew</recordid><startdate>2007</startdate><enddate>2007</enddate><creator>Leys, Charles M., MD, MSCI</creator><creator>Nomura, Sachiyo, MD, PhD</creator><creator>LaFleur, Bonnie J., PhD</creator><creator>Ferrone, Soldano, MD, PhD</creator><creator>Kaminishi, Michio, MD, PhD</creator><creator>Montgomery, Elizabeth, MD</creator><creator>Goldenring, James R., MD, PhD</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2007</creationdate><title>Expression and prognostic significance of prothymosin-α and ERp57 in human gastric cancer</title><author>Leys, Charles M., MD, MSCI ; Nomura, Sachiyo, MD, PhD ; LaFleur, Bonnie J., PhD ; Ferrone, Soldano, MD, PhD ; Kaminishi, Michio, MD, PhD ; Montgomery, Elizabeth, MD ; Goldenring, James R., MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-d86dd7ff6d2737fd8699d7322b7aa5f68f2e7a4b8d518c3975573ce79e55b2623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adenocarcinoma - metabolism</topic><topic>Adenocarcinoma - mortality</topic><topic>Adenocarcinoma - pathology</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Down-Regulation</topic><topic>Endoplasmic Reticulum - metabolism</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Metaplasia - metabolism</topic><topic>Molecular Chaperones - metabolism</topic><topic>Prognosis</topic><topic>Protein Array Analysis</topic><topic>Protein Disulfide-Isomerases - metabolism</topic><topic>Protein Precursors - metabolism</topic><topic>Retrospective Studies</topic><topic>Stomach - metabolism</topic><topic>Stomach - pathology</topic><topic>Stomach Neoplasms - metabolism</topic><topic>Stomach Neoplasms - mortality</topic><topic>Stomach Neoplasms - pathology</topic><topic>Surgery</topic><topic>Survival Rate</topic><topic>Thymosin - analogs &amp; derivatives</topic><topic>Thymosin - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leys, Charles M., MD, MSCI</creatorcontrib><creatorcontrib>Nomura, Sachiyo, MD, PhD</creatorcontrib><creatorcontrib>LaFleur, Bonnie J., PhD</creatorcontrib><creatorcontrib>Ferrone, Soldano, MD, PhD</creatorcontrib><creatorcontrib>Kaminishi, Michio, MD, PhD</creatorcontrib><creatorcontrib>Montgomery, Elizabeth, MD</creatorcontrib><creatorcontrib>Goldenring, James R., MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leys, Charles M., MD, MSCI</au><au>Nomura, Sachiyo, MD, PhD</au><au>LaFleur, Bonnie J., PhD</au><au>Ferrone, Soldano, MD, PhD</au><au>Kaminishi, Michio, MD, PhD</au><au>Montgomery, Elizabeth, MD</au><au>Goldenring, James R., MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression and prognostic significance of prothymosin-α and ERp57 in human gastric cancer</atitle><jtitle>Surgery</jtitle><addtitle>Surgery</addtitle><date>2007</date><risdate>2007</risdate><volume>141</volume><issue>1</issue><spage>41</spage><epage>50</epage><pages>41-50</pages><issn>0039-6060</issn><eissn>1532-7361</eissn><abstract>Purpose Prothymosin-α and ERp57 were previously identified as markers for gastric metaplasia in a mouse model of Helicobacter-induced gastric metaplasia and neoplasia. In this paper we assess whether the expression of these putative biomarkers in humans is correlated with gastric metaplasia and adenocarcinoma and clinical outcomes. Methods Eight tissue microarrays, containing 749 paraffin-embedded tissue cores from 164 gastric cancer patients, were stained for prothymosin-α and ERp57 by horseradish peroxidase immunohistochemical techniques. The proportion of stained cells per core was quantitated using the Ariol SL-50 automated image analysis system. Results Prothymosin-α stained a significantly higher percentage of nuclei in cancer and metastases compared with normal gastric mucosa. ERp57 staining was significantly decreased in cancer and metastases compared with both normal gastric mucosa and metaplasias. ERp57 expression also correlated with greater depth of tumor invasion and advanced stage of disease. Kaplan-Meier survival analysis determined that tumors with the highest quartile of ERp57 expression were statistically associated with longer postoperative survival. A Cox proportional hazard analysis showed that maintenance of ERp57 expression was associated with longer postoperative survival. Conclusions These results suggest that although prothymosin-α is overexpressed in gastric adenocarcinoma, it is not associated with alterations in survival. In contrast, loss of ERp57 expression correlated with more aggressive disease and could provide useful prognostic information for gastric cancer patients.</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>17188166</pmid><doi>10.1016/j.surg.2006.05.009</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0039-6060
ispartof Surgery, 2007, Vol.141 (1), p.41-50
issn 0039-6060
1532-7361
language eng
recordid cdi_proquest_miscellaneous_68377624
source Elsevier
subjects Adenocarcinoma - metabolism
Adenocarcinoma - mortality
Adenocarcinoma - pathology
Biomarkers, Tumor - metabolism
Down-Regulation
Endoplasmic Reticulum - metabolism
Humans
Immunohistochemistry
Metaplasia - metabolism
Molecular Chaperones - metabolism
Prognosis
Protein Array Analysis
Protein Disulfide-Isomerases - metabolism
Protein Precursors - metabolism
Retrospective Studies
Stomach - metabolism
Stomach - pathology
Stomach Neoplasms - metabolism
Stomach Neoplasms - mortality
Stomach Neoplasms - pathology
Surgery
Survival Rate
Thymosin - analogs & derivatives
Thymosin - metabolism
title Expression and prognostic significance of prothymosin-α and ERp57 in human gastric cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T15%3A19%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20and%20prognostic%20significance%20of%20prothymosin-%CE%B1%20and%20ERp57%20in%20human%20gastric%20cancer&rft.jtitle=Surgery&rft.au=Leys,%20Charles%20M.,%20MD,%20MSCI&rft.date=2007&rft.volume=141&rft.issue=1&rft.spage=41&rft.epage=50&rft.pages=41-50&rft.issn=0039-6060&rft.eissn=1532-7361&rft_id=info:doi/10.1016/j.surg.2006.05.009&rft_dat=%3Cproquest_cross%3E68377624%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c409t-d86dd7ff6d2737fd8699d7322b7aa5f68f2e7a4b8d518c3975573ce79e55b2623%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=68377624&rft_id=info:pmid/17188166&rfr_iscdi=true